Skip to main content

Table 1 Clinicopathological data of the cervical adenocarcinoma patients

From: Reprogramming energy metabolism and inducing angiogenesis: co-expression of monocarboxylate transporters with VEGF family members in cervical adenocarcinomas

Variable

n

%

Tobacco use (n = 117)

  

 No

83

70.9

 Yes

34

29.1

FIGO (n = 93)

  

 I

49

52.7

 II + III

44

47.3

Grade (n = 201)

  

 Low grade (I)

118

58.7

 High grade (II e III)

83

41.3

Tumor size (n = 36)

  

 <4 cm

27

75.0

 >4 cm

9

25.0

Parametrial invasion (n = 51)

  

 Absent

21

41.2

 Present

30

58.8

 Local metastasis (n = 98)

  

 Absent

73

74.5

 Present

25

25.5

Lymphnode metastasis (n = 81)

  

 Absent

68

84.0

 Present

13

16.0

Distant metastasis (n = 126)

  

 Absent

107

84.9

 Present

19

15.1

HPV type (n = 208)

  

 Negative

45

21.6

 16

98

47.1

 18

34

16.3

 16, 18

7

3.4

 45

6

2.9

 31

3

1.4

 39

3

1.4

 58

2

1.0

 18, 45

2

1.0

 11

1

0.5

 16, 45, 52

1

0.5

 16, 18, 11

1

0.5

 16, 74

1

0.5

 16, 52

1

0.5

 16, 11, 52

1

0.5

 16, 45

1

0.5

 16, 39

1

0.5